Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma.
Sosman JA, Carrillo C, Urba WJ, Flaherty L, Atkins MB, Clark JI, Dutcher J, Margolin KA, Mier J, Gollob J, Kirkwood JM, Panka DJ, Crosby NA, O'Boyle K, LaFleur B, Ernstoff MS.
Sosman JA, et al. Among authors: gollob j.
J Clin Oncol. 2008 May 10;26(14):2292-8. doi: 10.1200/JCO.2007.13.3165.
J Clin Oncol. 2008.
PMID: 18467720
Free PMC article.
Clinical Trial.